MMS
NYSE MAXIMUS, Inc.$58.87 ↑ +0.00 (+0.00%) Trading Up from the previous close of $58.87, $1.04 below the day’s high of $59.91
- YTD change
- -31.80%
- vs 20-day SMA
- +6.50%
- vs 200-day SMA
- -12.15%
Price ranges
Price & Performance
-8.48 (-12.59%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 41.1% away from all-time highs of $100.00
- MMS is down 32% since the beginning of the year
- MMS is down 31% over the past 12 months
- MMS is up 3% over the past 1 month
- 5% of all MMS investors are betting against MMS
- Number of investors short MMS has gone down 3% versus last month
MMS reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is -30.9%.
- Previous minute
- +$0.00
- Last hour
- -$0.34
- Last 5 days
- +11.81%
- vs 8-day SMA
- +6.49%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
MAXIMUS, Inc. engages in the operation of government health and human services programs, and the provision of technology solutions to government. It operates through the following segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers business process services (BPS), appeals and assessments, and related consulting work for U.S. state and local government programs. The U.S. Federal Services segment delivers end-to-end solutions and includes appeals and assessment services, system and application development, IT modernization, and maintenance services. The Outside the U.S segment provides BPS for international governments and commercial clients. The company was founded by David V. Mastran in 1975 and is headquartered in McLean, VA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
